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Objectives This study sought to compare fractional flow reserve (FFR) with the instantaneous wave-free ratio (iFR) in pa-
tients with coronary artery disease and also to determine whether the iFR is independent of hyperemia.
Background FFR is a validated index of coronary stenosis severity. FFR-guided percutaneous coronary intervention (PCI) im-
proves clinical outcomes compared to angiographic guidance alone. iFR has been proposed as a new index of
stenosis severity that can be measured without adenosine.
Methods We conducted a prospective, multicenter, international study of 206 consecutive patients referred for PCI and a
retrospective analysis of 500 archived pressure recordings. Aortic and distal coronary pressures were measured
in duplicate in patients under resting conditions and during intravenous adenosine infusion at 140 g/kg/min.
Results Compared to the FFR cut-off value of 0.80, the diagnostic accuracy of the iFR value of 0.80 was 60% (95% confi-
dence interval [CI]: 53% to 67%) for all vessels studied and 51% (95% CI: 43% to 59%) for those patients with FFR in
the range of 0.60 to 0.90. iFR was significantly influenced by the induction of hyperemia: mean  SD iFR at rest was
0.82  0.16 versus 0.64  0.18 with hyperemia (p  0.001). Receiver operating characteristics confirmed that the
diagnostic accuracy of iFR was similar to resting Pd/Pa and trans-stenotic pressure gradient and significantly inferior
to hyperemic iFR. Analysis of our retrospectively acquired dataset showed similar results.
Conclusions iFR correlates weakly with FFR and is not independent of hyperemia. iFR cannot be recommended for clinical deci-
sion making in patients with coronary artery disease. (Comparison of Fractional Flow Reserve Versus Instant Wave-
Free Ratio for Assessment of Coronary Artery Stenosis Severity in Routine Practice; NCT01559493) (J Am Coll Car-
diol 2013;61:1421–7) © 2013 by the American College of Cardiology Foundation
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.09.065Fractional flow reserve (FFR) is a pressure-derived index of
coronary stenosis severity and represents the ratio of maxi-
mal blood flow in a stenotic artery to maximal flow in the
same artery in the absence of any stenosis (1–4). It has been
well validated (5–7), and in patients with multivessel coro-
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Comparison of FFR Versus iFR April 2, 2013:1421–7compared to treatment based on
angiography alone (8–10). As a
result, FFR guidance during PCI
has received a class 1A recom-
mendation from the European
Society of Cardiology (11) and a
class IIA recommendation from
the American College of Cardiol-
ogy (12). FFR measurements re-
quire that myocardial resistance
is minimal and constant. In clin-
ical practice, intravenous adeno-
sine infusion is used to establish
these conditions. Although most
patients experience some breath-
lessness and chest tightness dur-
ing adenosine infusion, these
symptoms are generally well tolerated (13). The instanta-
neous wave-free ratio (iFR) has been proposed as an index
of stenosis severity that is independent of hyperemia and can
be measured without the need for adenosine (14). The
concept of iFR is based on the hypothesis that there is a
diastolic “wave-free” period (WFP) when microvascular
resistance is already constant and minimal. An iFR value
of 0.83 has been suggested as having diagnostic accu-
racy comparable to the commonly used FFR cutoff of
0.80. We studied consecutive unselected patients re-
ferred for angiography with or without PCI to compare
FFR to iFR and to determine whether iFR is indepen-
dent of hyperemia.
Methods
The study protocol was approved by the institutional review
board or ethics committee at each participating center, and
all patients provided written informed consent. This study is
registered at the National Institutes of Health Clinical
Figure 1 Pressure Tracings of 2 Sequential Heartbeats at Rest
The wave-free period (WFP) begins 25% into diastole and ends 5 ms before the end o
Both the systolic pressure gradient (light shade) and diastolic pressure gradient (dark
Abbreviations
and Acronyms
ACC  American College of
Cardiology
ESC  European Society of
Cardiology
FFR  fractional flow
reserve
iFR  instantaneous wave-
free ratio
Pa  aortic pressure
Pd  distal coronary
pressure
PCI  percutaneous
coronary interventionTrials website (NCT01559493). All consecutive patients
referred for FFR-guided angiography with or without PCI
during a 5-week period from January 4 to February 10, 2012,
During Hypermia Induced by Adenosine
ole. Aortic pressure is in red and distal coronary artery pressure is in green.
e) increase substantially during hyperemia.
Baseline Characteristics (n  206)Table 1 Baseline Characteristics (n  206)
Age (yrs) 65.2 10.2
Male 146 (71)
Mean body mass index (kg/m2) 27.7 4.6
Risk factors
Cigarette smoker 64 (31)
Diabetes 50 (24)
Hypercholesterolemia 127 (62)
Treated hypertension 137 (67)
Family history 71 (35)
Mean % of left ventricular ejection fraction 56 11
Stable angina 140 (68)
Unstable angina 46 (22)
No. of previous MIs in the culprit artery territory 28 (14)
Index artery
LAD 133 (64)
Cx 28 (14)
RCA 45 (22)
No significant disease 16 (8)
Single-vessel disease 85 (41)
Two-vessel disease 64 (31)
Three-vessel disease 41 (20)
Medication
Aspirin 181 (88)
Clopidogrel or ticagrelor or prasugrel 94 (46)
ACE inhibitor or ARB 139 (68)
Beta-blocker 161 (78)
Statin 169 (82)
Calcium antagonist 49 (24)
Long-acting nitrate 45 (22)
Insulin 19 (9)
Oral antidiabetes medication 33 (16)
Values are mean  SD or n (%).
ACE  angiotensin-converting enzyme; ARB  angiotensin receptor blocker; Cx  circumflex
coronary artery; LAD left anterior descending coronary artery; MImyocardial infarction; RCA
right coronary artery.and
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April 2, 2013:1421–7 Comparison of FFR Versus iFRwere included. Exclusion criteria were a history of coronary
artery bypass surgery, extremely tortuous coronary arteries,
an occluded coronary artery, severely calcified lesions, or a
history of acute myocardial infarction within 5 days. Retro-
spective analysis was conducted using archived pressure
recordings from 500 unselected patients from three of the
participating centers.
FFR was measured in one coronary artery in each patient
after the operator had identified potential targets for PCI.
The RadiAnalyzer Xpress instrument (St. Jude Medical,
Uppsala, Sweden) and a coronary pressure wire (Certus, St
Jude Medical, Uppsala, Sweden) were used in all cases.
After the coronary angiogram was obtained, the pressure
wire was zeroed, equalized, and positioned with the sensor
Figure 2 Scatterplots and Bland-Altman Plots of FFR Versus iF
(A and C) All vessel; (B and D) vessels with FFR 0.60 to 0.90. Lines of identity a
black line), a hinged regression line (not shown) was fitted by least squares and g
and a slope below it of 1.65; r is Spearman’s correlation. Limits of agreement, 
ferences are shown as solid lines. When FFR is low (0.60), the 95% mean  SD
Diagnostic Performance and Accuracy of iFR <0.80Table 2 Diagnostic Performance and Accuracy of iFR <0.80
Diagnosis % of FFR <0.80 (n) % of Sensitivity (95% CI) % of S
Prospective study
All FFRs (n  206) 65 (134) 40 (31–48)
FFRs 0.6–0.9 (n  160) 64 (103) 25 (17–35)
Retrospective study
All FFRs (n  497) 68 (339) 40 (35–46)
FFRs 0.6–0.9 (n  392) 70 (275) 28 (22–33)CI  confidence interval; NPV  negative predictive value; PPV  positive predictive value.in the distal third of the target artery. Two minutes after the
last injection of contrast medium, pressure recording com-
menced. After approximately 10 cardiac cycles, an intrave-
nous infusion of adenosine (140 g/kg/min) was adminis-
ered through a large antecubital or central vein. The
esponse to adenosine was confirmed by changes in heart
ate and blood pressure and development of typical symp-
oms. After a stable minimum value of FFR was established,
he adenosine infusion and pressure recording were stopped.
ollowing a 2-min rest period, the sequence was repeated to
est reproducibility of all indices. Finally a pullback record-
ng was performed to exclude wire drift.
iFR was measured as the ratio of mean distal coronary
ressure to mean aortic pressure during the diastolic WFP
the Prospective Dataset (n  206)
wn as dashed red lines. In addition to the linear regression shown (A, solid
slope of 0.67 above the hinge point of FFR  0.60 (x-axis) and 0.75 (y-axis)
o 0.27 (B) and 0.05 to 0.24 (D), are shown as dashed lines, and average dif-
of agreement (1.96) are wide (0.36, 0.23).
city (95% CI) % of PPV (95% CI) % of NPV (95% CI) % of Accuracy (95% CI)
3–100) 98 (90–100) 47 (39–55) 60 (53–67)
1–100) 96 (81–100) 42 (34–51) 51 (43–59)
7–100) 99 (96–100) 44 (38–49) 59 (54–63)
5–100) 99 (93–100) 37 (31–42) 49 (44–54)R for
re sho
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Comparison of FFR Versus iFR April 2, 2013:1421–7as described by Sen et al. (14) (Fig. 1). In order to determine
whether iFR was independent of hyperemia, mean Pd/Pa
during this period was also measured during adenosine
infusion (“hyperemic” iFR). All analyses were performed in
a fully automated manner without manual selection of data
time points.
Data management and statistics. For the prospective
study, a sample size of 189 subjects provided 90% power at
the 5% significance level to confirm a difference of 10% in
the diagnostic accuracy of iFR compared to FFR from a null
hypothesis value of 80%. We planned to recruit 200 patients
to account for any missing data. Clinical data without
patient identifiers and coronary pressure recordings were
submitted to a core laboratory (Department of Biomedical
Figure 3 iFR During Rest and Hypermia
With Mean  SD for Each Group
Mean difference: 0.18 (95% CI: 0.17 to 0.20), p  0.0001.
Diagnostic Performance and Accuracy of iFR <0.83Table 3 Diagnostic Performance and Accuracy of iFR <0.83
Diagnosis % of FFR <0.80 (n) % of Sensitivity (95% CI) % of
Prospective study
All FFRs (n  206) 65 (134) 54 (45–62)
FFRs 0.6–0.9 (n  160) 64 (103) 41 (31–51)
Retrospective study
All FFRs (n  497) 68 (339) 55 (49–60)
FFRs 0.6–0.9 (n  392) 70 (275) 45 (39–52)
CI  confidence interval; NPV  negative predictive value; PPV  positive predictive value.Engineering, University of Technology, Eindhoven, the
Netherlands). Coronary pressure recordings were exported
from RadiView software (version 2.2, St Jude Medical, Upp-
sala, Sweden) and analyzed using Matlab (Mathworks, Inc.,
Natick, Massachusetts). The relationship between FFR and
iFR was quantified with a coefficient of determination (r2).
Agreement between the methods was assessed by Bland-
Altman plots and 95% limits of agreement. The performance
of iFR was assessed using sensitivity, specificity, positive
predictive value (PPV), negative predictive value (NPV), and
diagnostic accuracy (the percentage of patients correctly diag-
nosed by iFR), together with their 95% confidence intervals
(CIs). iFR was compared to hyperemic iFR and other mea-
sures by using receiver operating characteristics (ROC) area
under the curve (AUC) analysis using the method described by
DeLong et al. (15). Analyses were performed with the entire
dataset and with the subgroup of patients with an FFR in the
range 0.60 to 0.90. Statistical analysis was performed by an
independent statistician (J.M.) with IBM SPSS version 19.0
(IBM Corp., Armonk, New York), Minitab version 16.0
Figure 4
ROC Curves for iFR (AUC  0.87), Hyperemic iFR
(iFRhyp; AUC  0.99, p < 0.000001), Distal Coro-
nary/Aortic Pressure Ratio at Rest (Pd/Pa; AUC 
0.88, p  0.52), and Resting Gradient Between Aortic
and Distal Coronary Pressures (AUC  0.87, p  0.77)
All p values are comparisons with iFR.
city (95% CI) % of PPV (95% CI) % of NPV (95% CI) % of Accuracy (95% CI)
88–99) 96 (89–99) 53 (44–62) 68 (61–75)
85–99) 93 (82–99) 47 (38–56) 60 (52–68)
95–99) 98 (95–100) 50 (44–56) 68 (64–72)
93–99) 98 (93–100) 43 (37–49) 61 (56–66)Specifi
96 (
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April 2, 2013:1421–7 Comparison of FFR Versus iFR(Minitab Inc., State College, Pennsylvania), and R (R Foun-
dation, Vienna, Austria) software.
Results
The clinical characteristics of the patients in the prospective
study are shown in Table 1. The relationships between FFR
and iFR are shown in Figure 2. Compared to the commonly
used FFR cut-off value of 0.80, the diagnostic perfor-
ance of iFR of 0.80 is shown in Table 2. Overall
accuracy was 60% (95% CI: 53% to 67%) for all vessels
studied and 51% (95% CI: 43% to 59%) for those with FFR
in the range of 0.60 to 0.90. Sen et al. (14) proposed that
iFR of 0.83 has diagnostic performance equivalent to an
FFR of0.80. The diagnostic performance of iFR at0.83
in our prospectively acquired dataset is shown in Table 3.
Overall accuracy was 68% (95% CI: 61% to 75%) for all
vessels studied and 60% (95% CI: 52% to 68%) for those
with FFR in the range of 0.60 to 0.90. iFR decreased
significantly with hyperemia: mean SD iFR at rest 0.82
0.16 versus 0.64  0.18 with hyperemia (95% CI for
difference 0.17 to 0.20; p0.0001) (Fig. 3). ROC con-
firmed that the diagnostic performance of iFR was similar to
that of resting Pd/Pa (p  0.52) and trans-stenotic pressure
gradient (p  0.77) and inferior to that of hyperemic iFR
Figure 5 Scatterplots and Bland-Altman Plots Showing the Rep
Line of identity is in red (dashed). (A and B) Linear regression equation line is sh
(C and D) Mean differences (solid black line) and 95% limits of agreement (dash(p  0.0001) (Fig. 4). Both iFR and FFR showed excellentreproducibility (Fig. 5). However, FFR had significantly
better reproducibility (p  0.000) with the iFR differences
having between 2.5 and 4.4 times larger variance than FFR
differences (95% CI and F-test to compare two variances).
The FFR 95% limits of agreement were 0.04 to 0.04; iFR
95% limits of agreement were wider (0.07 to 0.08),
particularly when iFR 0.8 (0.08 to 0.14). The relative
error (iFR  FFR/FFR) for heart rate (p  0.032) and
pressure rate product (p  0.032) indicated that iFR was
susceptible to variations in heart rate and blood pressure
during resting conditions. This is illustrated by the wider
spread of points in the iFR scatter plot than in the FFR
scatter plot (Fig. 5). Results of the analysis of our retrospec-
tively acquired dataset were consistent with those of the
prospective study (Table 2 and 3, Fig. 6). In Figure 6A (as
in Fig. 2A), in addition to the simple linear regression
shown (solid black line), a hinged regression line was fitted
by least squares and gave a slope of 0.62 above the hinge
point of FFR  0.63 (x-axis) and 0.78 (y-axis), and a slope
below it of 1.19.
Discussion
Our results show a moderate overall correlation between
FFR and iFR but only a weak correlation in the clinically
cibility of FFR and iFR
solid black.
ck lines) are shown.rodu
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ed blaimportant range for decision making of 0.60 to 0.90. Sen et
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Comparison of FFR Versus iFR April 2, 2013:1421–7al. (14) suggested that an iFR value of0.83 was equivalent
to the widely used and validated FFR cut-off value of
0.80. However, in our prospective study, the diagnostic
accuracy of iFR was unacceptably low using a cut-off value
of either 0.80 or 0.83. Almost identical results were found
n the retrospective study. We also found that iFR, which
s by definition a resting parameter and said to be
ndependent of hyperemia, did in fact change markedly
uring adenosine-induced hyperemia, a finding which
hallenges the underlying concept and clinical applicabil-
ty of iFR. Finally, we found that FFR and iFR had
omparable reproducibility.
Multiple experimental models and preclinical and clinical
tudies have established that neither blood flow nor trans-
tenotic pressure gradient at rest can determine whether a
tenosis in a coronary artery will limit myocardial perfusion
nder conditions of increasing demand. Only when hyper-
mia is induced and coronary flow reserve is measured can a
elationship between stenosis severity and the presence of
schemia be demonstrated (16–19). The hypothesis under-
ying iFR depends on accepting that mean resting myocar-
ial resistance during the WFP of diastole is minimal and
quivalent to mean resistance during maximal hyperemia
ver the complete cardiac cycle. However, this is clearly not
he case. Minimal diastolic resistance at rest (whether
Figure 6 Scatterplots and Bland-Altman Plots of FFR Versus iF
(A and C) All vessels; (B and D) vessels with FFR 0.60 to 0.90. Lines of identity
(B and D) Limits of agreement are shown as dashed lines (B: 0.05 to 0.25; D:easured during the whole of diastole or only during the lWFP) is generally 50% to 100% higher than the average
resistance over the complete heart cycle during hyperemia,
as is apparent from our observation of an average decrease in
iFR from rest to hyperemia of more than 100% relative to
the reduction of iFR from its normal value of 1.0. The
concept of iFR also depends on accepting that adenosine
exerts its predominant effect on coronary flow during systole
and does not influence mean resistance during the WFP in
diastole. This is also incorrect. Blood flow at rest in a normal
coronary artery is low during systole (because of high
resistance) and occurs primarily in diastole. During
adenosine-induced maximal hyperemia, coronary blood
flow and trans-stenotic pressure gradient increase in both
phases of the cardiac cycle but much more so during
diastole than systole (Fig. 1). Indeed the correlation
between FFR measured over the complete cardiac cycle
and diastolic Pd/Pa measured during hyperemia is much
closer than the correlation between iFR and FFR (20). In
addition to these considerations, the geometry of a
stenosis determines the relative magnitude of the friction
coefficient (f) and the separation coefficient (s), as de-
scribed by the equation P  fQ  sQ2, where P 
ressure and Q  flow (21, 22). In short, minimal resting
radients of severe lesions can increase substantially
uring hyperemia, whereas in long moderate lesions,
the Retrospective Dataset (n  500)
own as dashed red lines (r is Spearman’s correlation).
to 0.22), and average differences are shown as solid lines (0.10 for each).R for
are sh
0.02arge resting gradients may increase only minimally
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April 2, 2013:1421–7 Comparison of FFR Versus iFRduring hyperemia. Therefore, two different stenoses with
identical resting gradients (and therefore identical iFRs)
can generate completely different hyperemic gradients
(and therefore different FFRs).
Ultimately, the sole justification for replacing FFR with
iFR is the belief that removing the need to administer
adenosine will facilitate the use of pressure wire-guided
decision making. However, notwithstanding the poor diag-
nostic accuracy of iFR, intravenous adenosine infusions are
generally well tolerated particularly given the duration of
infusion for the measurement of FFR is only 30 to 120 s.
Any adverse reactions that do occur are short lived and
harmless, with severe asthma being the only absolute con-
traindication. In addition, when for practical reasons, intra-
venous adenosine is difficult to administer, it can be replaced
by intracoronary adenosine with similar results in most
clinical situations (13).
Conclusions
In summary, iFR is not independent of hyperemia, correlates
poorly with FFR, and has not been validated experimentally or
relative to any of the established noninvasive techniques for
identifying reversible myocardial ischemia, including the true
gold standard of repeat testing before and after revascularisa-
tion (4). Consequently, we believe that iFR cannot be recom-
mended for clinical decision making in patients with coronary
artery disease.
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